We describe an interesting case of a woman with decompensated cirrhosis, ischaemic heart
disease and prolonged QT interval, who developed a new-onset atrial fibrillation. During …

The anti-arrhythmic agent amiodarone (AD) is associated with numerous adverse effects,
but serious liver disease is rare. The improved safety of administration of daily low doses of …

Amiodarone is a widely used and effective long-term antiarrhythmic drug but with known
adverse effects. Prolonged oral administration of this drug has been implicated in numerous …

Amiodarone is an antiarrhythmic drug widely used to treat a variety of supraventricular and
ventricular arrhythmias. However its drawback is a very slow elimination and very frequent …

Amiodarone chlorhydrate is a diiodated benzofuran derivative used to treat cardiac rhythm
abnormalities. Hepatotoxicity is a relatively uncommon side effect of amiodarone and …

Amiodarone is one of the most effective antiarrhythmic drugs available and is widely
prescribed despite several potentially life-threatening side-effects. Hepatotoxicity is the most …

Amiodarone, a diiodinated benzofuran derivative, is widely used for treating ventricular and
supraventricular tachyarrhythmias. Amiodarone is highly lipophilic and accumulation in the …

The ECG QT interval measures the length of ventricular systole. Its prolongation is
essentially caused by a delayed repolarization phase, and is associated with an increased …

Adverse reactions to the antiarrhythmic medication amiodarone are severe, potentially life-
threatening, and not rare. One in three patients on long-term therapy experience elevated …

Abstract Approximately 30% to 70% of patients with cirrhosis have QT interval prolongation.
In patients without cirrhosis, QT prolongation is associated with an increased risk of …